Inventor
Zahra Shahrokh
Inventor
Weston, MA, US
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides20%
C12YEnzymes13%
C12NMicroorganisms or enzymes6%
B65BMachines, apparatus or devices for, or methods of, packaging articles or materials4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,065,308Methods and compositions for CNS delivery of heparan n-sulfatase202110,660,944Stable formulations for CNS delivery of arylsulfatase A202010,646,554Methods and compositions for CNS delivery of arylsulfatase A202010,493,149Stable anti-OSMR antibody formulation201910,456,454CNS delivery of therapeutic agents201910,391,170Stable anti-OSMR antibody formulation20199,770,410'Methods and compositions for CNS delivery of arylsulfatase A'20179,694,057'Stabilized compositions of proteins having a free thiol moiety'20179,320,711'Methods and compositions for CNS delivery of heparan N-sulfatase'20169,283,181'CNS delivery of therapeutic agents'20169,220,677'Methods and compositions for CNS delivery of iduronate-2-sulfatase'20159,072,785'Stabilized compositions of proteins having a free thiol moiety'20158,673,298'Stabilized compositions of proteins having a free thiol moeity'20148,652,468'Methods of binding TNF-α using anti-TNF-α antibody fragment-polymer conjugates'20148,545,837'Methods and compositions for CNS delivery of iduronate-2-sulfatase'20138,470,969'Apo-2 ligand/trail formulations'20138,147,830'Antibody fragment-polymer conjugates and uses of same'20127,855,066'Methods for making Apo-2 ligand using divalent metal ions'20107,842,668'Apo-2 ligand/trail formulations'20107,842,789'Antibody fragment-polymer conjugates and uses of same'20107,833,766'Stabilized compositions of proteins having a free thiol moiety'20107,741,285'APO-2 ligand/trail formulations'20107,741,282'ApO2 ligand/TRAIL formulations'20107,507,405'Antibody fragment-polymer conjugates and uses of same'20097,214,776'Antibody fragment-polymer conjugates and uses of same'20077,122,636'Antibody fragment-polymer conjugates and uses of same'20067,005,504'Antibody fragment-peg conjugates'20066,870,033'Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies'20056,468,532'Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates'20026,458,355'Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates'20026,171,586'Antibody formulation'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2014Patents assigned to GENENTECH INC (16)· patent assignee history
2001–2014Based in San Francisco, CA, US· patent location history
2010–2021Patents assigned to SHIRE HUMAN GENETIC THERAPIES (13)· patent assignee history
2010–2021Based in Weston, MA, US· patent location history
2012–2017Patents assigned to SHAHROKH ZAHRA (8)· patent assignee history
2013–2017Patents assigned to CALIAS PERICLES (4)· patent assignee history
2013–2017Patents assigned to PAN JING (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 16 | 2001–2014 |
| SHIRE HUMAN GENETIC THERAPIES | 13 | 2010–2021 |
| SHAHROKH ZAHRAself | 8 | 2012–2017 |
| CALIAS PERICLES | 4 | 2013–2017 |
| PAN JING | 4 | 2013–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Weston, Massachusetts, US | 20 | 2010–2021 |
| San Francisco, California, US | 11 | 2001–2014 |